Restoration of a tumorigenic phenotype by beta 2-microglobulin transfection to EL-4 mutant cells.
Open Access
- 1 March 1992
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 175 (3) , 843-846
- https://doi.org/10.1084/jem.175.3.843
Abstract
It has frequently been suggested that loss of beta 2-microglobulin (beta 2m) in tumor cells may lead to malignant progression due to escape from immunological recognition. Here, we directly tested the role of beta 2m expression in tumorigenicity. A beta 2 m loss mutant (C4.4-25-), selected from the murine lymphoma EL-4, showed a marked reduction in tumorigenicity as compared with EL-4 in normal C57B1/6 (B6) mice. The reduced tumorigenicity was directly related to beta 2 m expression. Transfection of an intact murine beta 2m gene markedly increased the tumorigenic potential. The reduced tumorigenicity of C4.4-25- compared with beta 2m transfected cells was observed also in athymic B6 nu/nu mice, but was abolished in B6 mice depleted of natural killer (NK) 1.1-positive cells. These results show that restoration of beta 2m expression can promote tumorigenicity and demonstrate for the first time that induction of major histocompatibility complex class I expression by transfection can lead to escape from NK cells in vivo.Keywords
This publication has 13 references indexed in Scilit:
- In search of the ‘missing self’: MHC molecules and NK cell recognitionPublished by Elsevier ,2003
- Alteration of the natural killer repertoire in H-2 transgenic mice: specificity of rapid lymphoma cell clearance determined by the H-2 phenotype of the target.The Journal of Experimental Medicine, 1991
- Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched miceNature, 1991
- Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants.The Journal of Immunology, 1990
- Altered growth of a human neuroendocrine carcinoma line after transfection of a major histocompatibility complex class I gene.Proceedings of the National Academy of Sciences, 1989
- Selective loss of beta 2-microglobulin mRNA in human colon carcinoma.The Journal of Experimental Medicine, 1989
- Partial suppression of anchorage-independent growth and tumorigenicity in immunodeficient mice by transfection of the H-2 class I gene H-2Ld into a human colon cancer cell line (HCT).Proceedings of the National Academy of Sciences, 1988
- Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyNature, 1986
- Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.The Journal of Experimental Medicine, 1985
- Major histocompatibility antigens: The human (HLA-A,-B,-C) and murine (H-2K, H-2D) class I moleculesCell, 1981